CAS: 849217-68-1 - 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
Fórmula:C28H24FN3O5
InChI:InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)
Clave InChI:InChIKey=ONIQOQHATWINJY-UHFFFAOYSA-N
SMILES:O=C(NC1=CC=C(F)C=C1)C2(C(=O)NC3=CC=C(OC=4C=CN=C5C=C(OC)C(OC)=CC54)C=C3)CC2
- Sinónimos:
- 1-N-[4-(6,7-Dimethoxyquinolin-4-yl)oxyphenyl]-1-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- Bms-907351
- Cabometyx
- Cabozantinib
- N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- Xl 184
- Xl184
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Cabozantinib REF: 4Z-C-284001CAS: 849217-68-1 | - - - | A consultar | Mar 07 Ene 25 | |
Cabozantinib REF: 7W-GW6378CAS: 849217-68-1 | - - - | 287,00 €~813,00 € | Lun 13 Ene 25 | |
Cabozantinib REF: TM-T2586CAS: 849217-68-1 | 99.59% - 99.88% | 46,00 €~244,00 € | Lun 13 Ene 25 | |
XL184 REF: TR-X745500CAS: 849217-68-1 | - - - | 108,00 €~296,00 € | Mar 14 Ene 25 | |
XL184 REF: 3D-FD59688CAS: 849217-68-1 | Min. 98 Area-% | 172,00 €~538,00 € | Mié 15 Ene 25 |
Cabozantinib
Ref: 4Z-C-284001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Ref: 7W-GW6378
10mg | 287,00 € | ||
50mg | 813,00 € |
Cabozantinib
Ref: TM-T2586
5mg | 46,00 € | ||
10mg | 59,00 € | ||
50mg | 78,00 € | ||
100mg | 94,00 € | ||
200mg | 150,00 € | ||
500mg | 244,00 € | ||
1mL*10mM (DMSO) | 51,00 € |
XL184
Producto controladoRef: TR-X745500
1g | 296,00 € | ||
250mg | 108,00 € | ||
500mg | 173,00 € |
XL184
Ref: 3D-FD59688
25mg | 172,00 € | ||
50mg | 197,00 € | ||
100mg | 236,00 € | ||
250mg | 369,00 € | ||
500mg | 538,00 € |